טוען...
Alpha‐Synuclein as a Biomarker for Parkinson's Disease
Parkinson's disease (PD) is a common neurodegenerative disorder, characterized pathologically by the presence of α‐synuclein (α‐syn)‐rich Lewy bodies. As clinical diagnosis of PD is challenging, misdiagnosis is common, highlighting the need for disease‐specific and early stage biomarkers. Both...
שמור ב:
| הוצא לאור ב: | Brain Pathol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6245641/ https://ncbi.nlm.nih.gov/pubmed/26940058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12370 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|